Investigation of Effectiveness of Nowarta110 Against Murine Malignant Melanoma in an Implanted Animal Model
Anticancer Research · 2024
DOI: 10.21873/anticanres.17349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Jon Sin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, U.S.A. Hauptthemen laut MEDLINE: Mice, Inbred BALB C, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, U.S.A.
- BATTS Laboratories, Chatsworth, CA, U.S.A.
- University of California Irvine, Newport Beach, CA, U.S.A.
- Orange County Immune Institute, Huntington Beach, CA, U.S.A.
- Inventive Medical Foundation, South El Monte, CA, U.S.A.
- USC-Fobic Therapeutic Innovation Initiative, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, U.S.A.
Zitieren
APA
Sin, J., Kiosea, M., Kiosea, N., Mahdavi, K., Akbarpour, F., Tran, H. N., Han, B. O., & Hoang, B. X. (2024). Investigation of Effectiveness of Nowarta110 Against Murine Malignant Melanoma in an Implanted Animal Model. Anticancer Research. https://doi.org/10.21873/anticanres.17349
Vancouver
Sin J, Kiosea M, Kiosea N, Mahdavi K, Akbarpour F, Tran HN, et al. Investigation of Effectiveness of Nowarta110 Against Murine Malignant Melanoma in an Implanted Animal Model. Anticancer Research. 2024. doi:10.21873/anticanres.17349
BibTeX
@article{Sin2024,
author = {Sin, Jon and Kiosea, Matei and Kiosea, Nicolae and Mahdavi, Khosrow and Akbarpour, Ferre and Tran, Hong-An N and Han, B O and Hoang, Ba X},
title = {Investigation of Effectiveness of Nowarta110 Against Murine Malignant Melanoma in an Implanted Animal Model},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17349}
}
EUVIMED